Carbiotix AB is a pre-clinical stage therapeutics company. It engages in the provision of products and medicines that produce good bacteria from intestine to counter metabolic and chronic diseases. The company was founded in 2014 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company